Moxibustion for Fetus in Breech Presentation
Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting. The hypothesis is that moxibustion increase the likelihood of cephalic version.
Design: Randomised controlled trial Setting: University hospital. Population: A total of 212 consenting women between 34 and 36 weeks of gestation with a single fetus in breech presentation will be randomised to moxibustion (n=106) or expectant management (n=106).
Main Outcome Measure: Cephalic presentation at delivery or before external cephalic version.
|Breech Presentation||Procedure: Moxibustion of the BL67 acupoint||Phase 3|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Treatment
|Official Title:||Moxibustion for Fetus in Breech Presentation|
- Cephalic presentation at delivery or before external cephalic version [ Time Frame: end of pregnancy ]
- Mode of delivery [ Time Frame: end of pregnancy ]
- Women's views on the intervention [ Time Frame: end of pregnancy ]
- External cephalic version [ Time Frame: end of pregnancy ]
|Study Start Date:||October 2004|
|Study Completion Date:||January 2009|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
Procedure: Moxibustion of the BL67 acupoint
Moxibustion sessions every day (every other day in hospital, self-administration at home the other day) during a maximum of 14 days. Stopped if cephalic version.
|No Intervention: Control|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00890474
|Hôpitaux Universitaires de Genève|